Peroxisome Proliferator-Activated Receptor &ggr;: Implications for Cardiovascular Disease
作者:
Willa Hsueh,
Dennis Bruemmer,
期刊:
Hypertension: Journal of The American Heart Association
(OVID Available online 2004)
卷期:
Volume 43,
issue 2, Part 2
页码: 297-305
ISSN:0194-911X
年代: 2004
出版商: OVID
关键词: atherosclerosis;diabetes mellitus;peroxisome proliferator-activated receptor;angiotensin;inflammation
数据来源: OVID
摘要:
Abstract—Peroxisome proliferator-activated receptor &ggr; (PPAR&ggr;) is a ligand-activated transcription factor belonging to the nuclear hormone receptor superfamily. PPAR&ggr; is expressed by macrophages, endothelial cells, and vascular smooth muscle cells. It regulates gene expression of key proteins involved in lipid metabolism, vascular inflammation, and proliferation contributing to atherogenesis and postangioplasty restenosis. The discovery of synthetic ligands for PPAR&ggr; has led to significant enhancement of our understanding of the mechanism of their ligand-dependent activation and subsequent biological effects, particularly with respect to the role of PPAR&ggr; in vascular pathophysiology. The thiazolidinedione PPAR&ggr; agonists not only improve insulin resistance in patients with type II diabetes but also exert a broad spectrum of antiatherogenic effects in vitro and in animal models of atherosclerosis. In this review, we summarize the important role of PPAR&ggr; as a molecular target for thiazolidinediones and its implications for the control of vascular inflammation and proliferation for the cardiovascular system.
点击下载:
PDF
(222KB)
返 回